Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

NN1177 (TFA)

NN1177 (NNC9204-1177) TFA is a long-acting GLP-1/glucagon receptor co-agonist. NN1177 TFA can induce a dose-dependent body weight loss in diet-induced obese (DIO) mice[1][2].

Product Specifications

Product Name Alternative

NNC9204-1177 (TFA)

UNSPSC

12352209

Target

Cytochrome P450; GCGR; GLP Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/nn1177-tfa.html

Purity

98.66

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(NC(C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)[C@@H](C)O)=O)CCCCNC(CC[C@H](NC(CC[C@@H](C(O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC(CC[C@H](NC(CC[C@H](NC(CCCCCCCCCCCCCCCCC(O)=O)=O)C(O)=O)=O)C(O)=O)=O)CO)=O)CCC(O)=O)=O)CO)=O)=O)C(O)=O)=O)=O)CC(C)C)=O)CC(C)C)=O)CC1=CNC2=CC=CC=C12)=O)CCC(N)=O)=O)C(C)C)=O)CC3=CC=CC=C3)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)C)=O)CCCNC(N)=N)=O)CCCCN)=O)CO)=O)CCC(O)=O)=O)CC(C)C)=O)CC4=CC=C(O)C=C4)=O)CCCCN)=O)CO)=O)CC(C)C)=O)CC(O)=O)=O)CO)=O)[C@@H](C)O)=O)CC5=CC=CC=C5)=O)[C@@H](C)O)=O)=O)CCC(N)=O)=O)(C)C)[C@@H](N)CC6=CNC=N6.OC(C(F)(F)F)=O.[x]

Molecular Formula

C206H323N51O66.xC2HF3O2

Molecular Weight

4570.07 (free base)

References & Citations

[1]Simonsen L, et al. Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. PLoS One. 2022 Mar 4;17 (3) :e0264974.|[2]Monfeuga T, et al. Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patients. Mol Metab. 2023 Dec 7;79:101850.|[3]Säll C, et al. In vitro CYP450 enzyme down-regulation by GLP-1/glucagon co-agonist does not translate to observed drug-drug interactions in the clinic. Drug Metab Dispos. 2022 Jun 9:DMD-AR-2022-000865.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

Scientific Category

Peptides

Clinical Information

Phase 1

Isoform

CYP3A4

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

RGD1559708 3'UTR GFP Stable Cell Line
TU268070 1.0 mL

RGD1559708 3'UTR GFP Stable Cell Line

Sign In for Pricing
View Details
SIN3A (D1B7) Rabbit Monoclonal Antibody
CST 7691S 100 µL

SIN3A (D1B7) Rabbit Monoclonal Antibody

Sign In for Pricing
View Details
CKAP4 antibody
70R-6704 50 ug

CKAP4 antibody

Sign In for Pricing
View Details
PIM1 Antibody, FITC conjugated
CSB-PA02959C0Rb-01 50 µg

PIM1 Antibody, FITC conjugated

Sign In for Pricing
View Details
PIM1 Antibody, FITC conjugated
CSB-PA02959C0Rb-02 100 µg

PIM1 Antibody, FITC conjugated

Sign In for Pricing
View Details
Canine NUP155 ELISA Kit
ECN0058 96 Tests

Canine NUP155 ELISA Kit

Sign In for Pricing
View Details